Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Manger

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Annals of the Rheumatic Diseases|May 15, 2002
Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertensionT K Kvien, H K Zeidler, P Hannonen, et al.
MMW Fortschritte Der Medizin|July 12, 2007
[Current therapeutic strategy for rheumatoid arthritis]J Wollenhaupt, R Alten, H Burkhardt, et al.
Annals of the Rheumatic Diseases|October 10, 2009
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesionsF Van den Bosch, B Manger, P Goupille, et al.
British Journal of Rheumatology|September 12, 1998
Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral goldH K Zeidler, T K Kvien, P Hannonen, et al.
Zeitschrift Fur Rheumatologie|March 5, 2014
[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative]I H Tarner, K Albrecht, M Fleck, et al.
Zeitschrift Fur Rheumatologie|October 15, 2021
[Development of quality standards for patients with rheumatoid arthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Annals of the Rheumatic Diseases|May 27, 2006
Assessing the intra- and inter-reader reliability of dynamic ultrasound images in power Doppler ultrasonographyJ M Koski, S Saarakkala, M Helle, et al.
Rheumatology (Oxford, England)|March 21, 2000
Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study GroupD E Yocum, S Allard, S B Cohen, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Annals of the Rheumatic Diseases|May 15, 2002
Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertensionT K Kvien, H K Zeidler, P Hannonen, et al.
MMW Fortschritte Der Medizin|July 12, 2007
[Current therapeutic strategy for rheumatoid arthritis]J Wollenhaupt, R Alten, H Burkhardt, et al.
Annals of the Rheumatic Diseases|October 10, 2009
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesionsF Van den Bosch, B Manger, P Goupille, et al.
British Journal of Rheumatology|September 12, 1998
Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral goldH K Zeidler, T K Kvien, P Hannonen, et al.
Zeitschrift Fur Rheumatologie|March 5, 2014
[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative]I H Tarner, K Albrecht, M Fleck, et al.
Zeitschrift Fur Rheumatologie|October 15, 2021
[Development of quality standards for patients with rheumatoid arthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Annals of the Rheumatic Diseases|May 27, 2006
Assessing the intra- and inter-reader reliability of dynamic ultrasound images in power Doppler ultrasonographyJ M Koski, S Saarakkala, M Helle, et al.
Rheumatology (Oxford, England)|March 21, 2000
Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study GroupD E Yocum, S Allard, S B Cohen, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Pageof 17